يعرض 2,341 - 2,360 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( ((significant factor) OR (significant inverse)) decrease ))', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 2341

    Sequence analysis results. حسب Oejin Shin (20855617)

    منشور في 2025
    الموضوعات:
  2. 2342
  3. 2343
  4. 2344

    Descriptive analysis. حسب Oejin Shin (20855617)

    منشور في 2025
    الموضوعات:
  5. 2345

    Changes in the neutrophil count. حسب Lu Yang (30847)

    منشور في 2025
    "…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…"
  6. 2346

    Changes in the platelet count. حسب Lu Yang (30847)

    منشور في 2025
    "…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…"
  7. 2347

    Changes in the white blood cell count. حسب Lu Yang (30847)

    منشور في 2025
    "…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…"
  8. 2348

    Changes in the hemoglobin. حسب Lu Yang (30847)

    منشور في 2025
    "…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…"
  9. 2349

    WBC and ANC on day 7 post-chemotherapy. حسب Lu Yang (30847)

    منشور في 2025
    "…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…"
  10. 2350

    General clinical data of 88 patients with NPC. حسب Lu Yang (30847)

    منشور في 2025
    "…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…"
  11. 2351

    CONSORT participant flow diagram. حسب Lu Yang (30847)

    منشور في 2025
    "…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…"
  12. 2352

    S4 File - حسب Lu Yang (30847)

    منشور في 2025
    "…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…"
  13. 2353

    Results comparison and error analysis. حسب Changxi Shan (22493205)

    منشور في 2025
    الموضوعات:
  14. 2354

    ABR pipe buried experimental design. حسب Changxi Shan (22493205)

    منشور في 2025
    الموضوعات:
  15. 2355

    Properties of soil. حسب Changxi Shan (22493205)

    منشور في 2025
    الموضوعات:
  16. 2356

    Design of experimental loading. حسب Changxi Shan (22493205)

    منشور في 2025
    الموضوعات:
  17. 2357

    Loading pattern. حسب Changxi Shan (22493205)

    منشور في 2025
    الموضوعات:
  18. 2358

    Finite element simulation results. حسب Changxi Shan (22493205)

    منشور في 2025
    الموضوعات:
  19. 2359

    Constitutive curve of ABR pipe material. حسب Changxi Shan (22493205)

    منشور في 2025
    الموضوعات:
  20. 2360

    Location of vehicle. حسب Changxi Shan (22493205)

    منشور في 2025
    الموضوعات: